| Old Articles: <Older 27551-27560 Newer> |
 |
The Motley Fool December 5, 2007 David Lee Smith |
Superior Well: A Superior Investment? Superior Well helps producing companies wring as much oil and gas from their wells as possible. Unlike other oilfield service companies, they have found growth from Pennsylvania.  |
The Motley Fool December 5, 2007 Morgan Housel |
VeriFone's Bad Accounting Blip Shareholders of electronic-payment terminal manufacturer VeriFone got a nasty jolt Monday, after the company announced an earnings restatement that slashed shares by nearly 45%.  |
The Motley Fool December 5, 2007 Morgan Housel |
NBC Says Sayonara to iTunes NBC Universal confirmed that it won't renew its contract with iTunes. The move should be no surprise to anyone monitoring the recent bickering between Apple and NBC.  |
The Motley Fool December 5, 2007 Anders Bylund |
Google Apps Won't Kill Microsoft Office Google has business ambitions in the productivity software field, but no plans to own the whole market.  |
The Motley Fool December 5, 2007 Morgan Housel |
3 CEOs Who Should Go Nobody is perfect, but these guys should be shown the door. Now. Read on about Angelo Mozilo... James Tobin... John Mackey...  |
The Motley Fool December 5, 2007 Rich Smith |
Foolish Forecast: Korn/Ferry en Route In advance of earnings, analysts expect headhunting firm Korn/Ferry to show revenue growth of 16%, but in contrast, to grow profits only by 10%.  |
The Motley Fool December 5, 2007 Sham Gad |
How to Dodge the Debt You can do well as an investor despite our growing debt level.  |
The Motley Fool December 5, 2007 Rich Smith |
Foolish Forecast: 8 in a Row for Synopsys In advance of earnings, analysts wonder whether Synopsys will beat their estimates for the eighth quarter in a row.  |
The Motley Fool December 5, 2007 Brian Orelli |
Early Bird Gets the MS Worm Teva's multiple sclerosis drug COPAXONE performs well in a label-expanding trial.  |
The Motley Fool December 5, 2007 Brian Orelli |
Merck Stays Conservative Merck sets the bar low with its 2008 guidance. Is the company being overly cautious?  |
| <Older 27551-27560 Newer> Return to current articles. |